The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an initial investment of approximately $55 million for rapid development of VIR-2482, the Vir ...

Vir Biotechnology plans to give an exclusive license for the commercial rights to a chronic hepatitis delta treatment to an affiliate of Norgine. The biopharmaceutical company said Tuesday the license ...

Many racetracks have succumbed to high real-estate prices in recent years, their sweeping turns or steep banking replaced by subdivisions or warehouses. At least for now, Virginia International ...

Investing.com - Leerink Partners reiterated an Outperform rating and $16.00 price target on Vir Biotechnology (NASDAQ:VIR) following Mirum’s acquisition of private company Bluejay. VIR shares, ...

Actor-comedian Vir Das is set to make his directorial debut with an upcoming spy-comedy film, Happy Patel: Khatarnak Jasoos, backed by Aamir Khan Productions. The banner made the announcement by ...

The comedian Vir Das, who has gained international fame despite intense criticism in his native India, has taken up boxing. He says it’s “good prep for adversity.” Vir Das, a comedian, feels boxing is ...

Today is shaping up negative for Vir Biotechnology, Inc. (NASDAQ:VIR) shareholders, with the analysts delivering a substantial negative revision to next year's forecasts. Revenue estimates were cut ...

The Central Government has released a gazette notification listing gallantry award citations for defence personnel from multiple operations, including Operation Sindoor. The citations highlight acts ...

– Phase 1 clinical trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5500 in combination with androgen receptor pathway inhibitors in first-line mCRPC – Clinical ...

BofA Securities has upgraded Vir Biotechnology (NASDAQ:VIR) to buy from neutral saying that the market is underestimating the company's phase 3 combo treatment for severe liver disease caused ...

Marianne De Backer, PhD, MBA, CEO of Vir Biotechnology, has led the company's pivot to focusing on cancer as well as infectious diseases. [Vir Biotechnology] Between launching clinical studies for its ...